Your session is about to expire
← Back to Search
Anodyne Therapy for Lower Extremity Ischemic Pain (DTSC Trial)
DTSC Trial Summary
This trial will test whether a combination of two therapies, Monochromatic Infrared Photo Energy (MIRE) and Transcutaneous Electrical Nerve Stimulation (TENS), is effective in treating lower extremity pathologies derived from neurological ischemia disorders.
DTSC Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.DTSC Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Group 1: Anodyne
Frequently Asked Questions
Are new participants currently being sought for this experiment?
"Per clinicaltrials.gov, the trial originally posted on March 1st 2012 has ceased recruitment efforts and was last updated October 22nd 2022; however there are still 405 alternative trials that continue to accept participants."
Are those who are younger than 35 eligible for this experiment?
"The parameters for qualification in this trial stipulate that participants must be aged between 25 and 90 years old. Simultaneously, there are 32 clinical trials available to those under 18 and 377 to individuals over 65."
What number of medical centers are actively engaged in this research endeavor?
"Four research facilities are currently running this trial, including Erie Medical and Rehab in Erie, Silsbee Family Medicine PA in Silsbee, Curequest Clinical LLC in Jacksonville; other sites are also participating."
What criteria must a person satisfy to be accepted into this research?
"This trial necessitates an enrollment of 1000 individuals aged 25 to 90 suffering from lower extremity issues. Furthermore, the participants must have a high likelihood of surviving five years in addition to adhering to all study visit schedules as judged by the investigator."
Share this study with friends
Copy Link
Messenger